Grant: Discovery Grants Program - Individual
Université de Montréal
$64,000.00
Uncovering a New Cytotoxic Mechanism of Natural Killer Cells
EF 2023-24
Résumé
Natural Killer (NK) cells are known for their ability to kill infected or malignant cells. For many years, based on data obtained using traditional assays, several malignant cells were considered to be resistant to NK-cell mediated killing. Using acute lymphoblastic leukemia (ALL) cell lines as a model, we demonstrated that this apparent resistance was rather delayed killing relying on an undescribed cytotoxic pathway that does not involve granule exocytosis or the death receptors cytotoxic pathways. Interestingly, we found that gp91phox, classically involved in the NADPH oxidase complex, is necessary for this killing, unlike other components of the NADPH oxidase. Indeed, we observed that perforin-deficient NKAES and degranulation-deficient NKAES could kill efficiently ALL cells. Also, ALL cells stably transduced with FADD-dominant negative, which prevents death receptor apoptotic signaling, were still killed by NKAES cells. On the other hand, gp91phox-deficient NKAES cells could not kill ALL cells. Although NADPH oxidase has never been reported to be expressed in NK cells, our results indicate that gp91 is actually expressed in NK cells despite the absence of the flavocytochrome b558, suggesting that it could be involved in an alternative complex. In addition, we observed that metabolic modifications occurring in NK cells during ALL killing were very different from the ones observed during classical cytotoxic pathways. We propose to further decipher this new cytotoxic pathway by: 1. Identifying NK cell metabolism modifications and studying the role of gp91 during this new cytotoxic pathway. Transcriptomic and SeaHorse data analyses on NKAES cells suggest that metabolism is at the root of this new cytotoxic pathway. To understand the implication of metabolic modifications in this new cytotoxic pathway, we will study the oxphos and glycolysis of NKAES cells facing ALL. Moreover, our data suggest that gp91 is expressed in NK cells but not in the classical NADPH oxidase complex. We will characterize the cell localization of gp91 and its partners. 2. Identification of the NK-cell induced death processes in target cells. Our data suggest that death mediated by NK cells via our new cytotoxic pathway occurs through a mechanism that does not require caspase activation or mitochondrial depolarization. We will compare the transcriptome of NKAES-sensitive and resistant targets, and we will use CRISPR library on target cell lines to identify the pathways responsible for sensitivity to this new cytotoxic pathway. The understanding of this new cytotoxic pathway would represent a real breakthrough in NK cell biology. Our preliminary data and our expertise in NK cell biology position our team in a strategic situation to achieve our goals.
Programme
Discovery Grants Program - Individual
Bénéficiaire
Emplacement
Quebec, Canada
Type de bénéficiaire
Academia
Type
Grant
Source
NSERC's Awards Data
Tel que publié
Application id
RGPIN-2019-05042
Name nom
Haddad, Elie
Department département
Pédiatrie
Organization id
63
Institution établissement
Université de Montréal
Province en
Québec
Province fr
Québec
Country en
CANADA
Country fr
CANADA
Fiscal year exercice financier
2023
Competition year année de concours
2019
Award amount
64000
Program id
RGPIN
Program name en
Discovery Grants Program - Individual
Program name fr
Programme de subventions à la découverte - individuelles
Group en
DISCOVERY RESEARCH
Group fr
RECHERCHE AXÉE SUR LA DÉCOUVERTE
Committee code
1501
Committee name en
Genes, Cells and Molecules
Committee name fr
Gènes, cellules et molécules
Area of application code
1201
Area of application group en
Advancement of knowledge
Area of application group fr
Avancement des connaissances
Area of application en
Life sciences (including biotechnology)
Area of application fr
Sciences de la vie (y compris biotechnologie)
Research subject code
5305
Research subject group en
Molecular biology
Research subject group fr
Protein manipulation and expression
Research subject en
Biologie moléculaire
Research subject fr
Expression et recombinaison protéiques
Application title
Uncovering a New Cytotoxic Mechanism of Natural Killer Cells
Keyword
apoptosis; cell death processes; CRISPR library; gp91; mechanisms of cytotoxicity; NADPH; Natural Killer cells; oxidation
Application summary
Natural Killer (NK) cells are known for their ability to kill infected or malignant cells. For many years, based on data obtained using traditional assays, several malignant cells were considered to be resistant to NK-cell mediated killing. Using acute lymphoblastic leukemia (ALL) cell lines as a model, we demonstrated that this apparent resistance was rather delayed killing relying on an undescribed cytotoxic pathway that does not involve granule exocytosis or the death receptors cytotoxic pathways. Interestingly, we found that gp91phox, classically involved in the NADPH oxidase complex, is necessary for this killing, unlike other components of the NADPH oxidase. Indeed, we observed that perforin-deficient NKAES and degranulation-deficient NKAES could kill efficiently ALL cells. Also, ALL cells stably transduced with FADD-dominant negative, which prevents death receptor apoptotic signaling, were still killed by NKAES cells. On the other hand, gp91phox-deficient NKAES cells could not kill ALL cells. Although NADPH oxidase has never been reported to be expressed in NK cells, our results indicate that gp91 is actually expressed in NK cells despite the absence of the flavocytochrome b558, suggesting that it could be involved in an alternative complex. In addition, we observed that metabolic modifications occurring in NK cells during ALL killing were very different from the ones observed during classical cytotoxic pathways. We propose to further decipher this new cytotoxic pathway by: 1. Identifying NK cell metabolism modifications and studying the role of gp91 during this new cytotoxic pathway. Transcriptomic and SeaHorse data analyses on NKAES cells suggest that metabolism is at the root of this new cytotoxic pathway. To understand the implication of metabolic modifications in this new cytotoxic pathway, we will study the oxphos and glycolysis of NKAES cells facing ALL. Moreover, our data suggest that gp91 is expressed in NK cells but not in the classical NADPH oxidase complex. We will characterize the cell localization of gp91 and its partners. 2. Identification of the NK-cell induced death processes in target cells. Our data suggest that death mediated by NK cells via our new cytotoxic pathway occurs through a mechanism that does not require caspase activation or mitochondrial depolarization. We will compare the transcriptome of NKAES-sensitive and resistant targets, and we will use CRISPR library on target cell lines to identify the pathways responsible for sensitivity to this new cytotoxic pathway. The understanding of this new cytotoxic pathway would represent a real breakthrough in NK cell biology. Our preliminary data and our expertise in NK cell biology position our team in a strategic situation to achieve our goals.